Ten years on is the tenth annual report from the Deloitte Centre for Health Solutions exploring the performance of the biopharmaceutical industry and its ability to generate returns from investment in innovative new products.
After several months of crisis, Medicines for Europe lays out some of the key lessons learned from COVID-19 for the future of pharmaceutical policy in Europe. The COVID-19 outbreak in…
The Deloitte Intelligent biopharma series explores how artificial intelligence (AI) technologies will affect each step of the biopharma value chain. This report, the second in our series, examines how AI…
A major new report led by the Novartis Foundation and Microsoft shows how investment in data and AI is critical to drive the health system improvements needed to respond to…
See our Cookie Privacy Policy Here
